Skip to main content

Table 2 Details of the multi-organ dysfunction on day 3

From: Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study

Outcomes

Dexamethasone

Methylprednisolone

P-value

Best GCS (Without sedation) at day#3, Median (Q1,Q3)

15.0 (9.00, 15.00)

10.5 (3.00, 15.00)

0.0025^

CVP at day#3, Median (Q1,Q3)

8.0 (8.00, 8.00)

8.0 (8.00, 12.00)

0.0318^

Heart rate at day#3, Median (Q1,Q3)

75.0 (62.00, 89.00)

88.0 (76.00, 100.00)

0.0001^

Pressure adjusted heart rate at day3, Median (Q1,Q3)

9.0 (7.32, 11.43)

10.9 (8.41, 15.69)

0.0003^

MAP at day#3, Median (Q1,Q3)

73.0 (65.00, 82.00)

70.0 (63.00, 81.00)

0.2446*

PaO2/FiO2 (Lowest) at day3, Median (Q1,Q3)

120.8 (80.50, 190.00)

145.0 (100.00, 235.50)

0.0311^

Platelets count (Lowest) at day3, Median (Q1,Q3)

261.0 (202.00, 338.00)

300.0 (199.00, 375.00)

0.0836^

Serum creatinine (Highest) at day3, Median (Q1,Q3)

84.0 (66.00, 130.00)

96.0 (68.00, 196.00)

0.1386^

Total Bilirubin (Highest) at day3, Median (Q1,Q3)

9.0 (6.70, 13.00)

10.8 (6.90, 17.80)

0.2434^

  1. *T –Test
  2. ^Wilcoxon rank sum test is used to calculate the P-value